(VIANEWS) – VÅR ENERGI (VAR.OL), KID (KID.OL), VISTIN PHARMA (VISTN.OL) are the highest sales growth and return on equity stocks on this list.
Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?
1. VÅR ENERGI (VAR.OL)
34.3% sales growth and 50.7% return on equity
Vår Energi AS operates as an independent upstream oil and gas company on the Norwegian continental shelf in Norway. It produces crude oil, liquified natural gas, and natural gas liquids. The company was formerly known as Eni Norge AS and changed its name to Vår Energi AS in December 2018. The company was incorporated in 1965 and is headquartered in Sandnes, Norway. Vår Energi AS operates as a subsidiary of Eni International B.V.
Earnings Per Share
As for profitability, VÅR ENERGI has a trailing twelve months EPS of kr2.73.
PE Ratio
VÅR ENERGI has a trailing twelve months price to earnings ratio of 11.92. Meaning, the purchaser of the share is investing kr11.92 for every norwegian krone of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 50.7%.
Dividend Yield
As claimed by Morningstar, Inc., the next dividend payment is on Jul 29, 2024, the estimated forward annual dividend rate is 4.74 and the estimated forward annual dividend yield is 14.15%.
Revenue Growth
Year-on-year quarterly revenue growth grew by 35%, now sitting on 7.18B for the twelve trailing months.
Sales Growth
VÅR ENERGI’s sales growth is 34.6% for the current quarter and 34.3% for the next.
Moving Average
VÅR ENERGI’s value is under its 50-day moving average of kr35.30 and under its 200-day moving average of kr34.24.
More news about VÅR ENERGI.
2. KID (KID.OL)
7.5% sales growth and 29.84% return on equity
Kid ASA, together with its subsidiaries, operates as a home textile retailer in Norway, Sweden, Finland, and Estonia. It designs, sources, markets, and sells a range of home and interior products, including textiles, curtains, bed linens, home accessories, decorations, furniture, and other interior products through retail stores and online platforms. The company provides its products under the Kid, Hemtex, Dekosol, Nordun, and Premium Collection brands. It also offers logistics services. The company was formerly known as Nordisk Tekstil Holding AS and changed its name to Kid ASA. Kid ASA was founded in 1937 and is headquartered in Lier, Norway.
Earnings Per Share
As for profitability, KID has a trailing twelve months EPS of kr8.94.
PE Ratio
KID has a trailing twelve months price to earnings ratio of 16.64. Meaning, the purchaser of the share is investing kr16.64 for every norwegian krone of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 29.84%.
Volume
Today’s last reported volume for KID is 12691 which is 65.07% below its average volume of 36335.
More news about KID.
3. VISTIN PHARMA (VISTN.OL)
6.6% sales growth and 23.89% return on equity
Vistin Pharma ASA, through its subsidiary, Vistin Pharma AS, produces and sells active pharmaceutical ingredients (APIs) worldwide. It offers metformin HCl APIs and direct compressive granulates for the pharmaceutical industry. Vistin Pharma ASA was founded in 1969 and is headquartered in Oslo, Norway.
Earnings Per Share
As for profitability, VISTIN PHARMA has a trailing twelve months EPS of kr1.54.
PE Ratio
VISTIN PHARMA has a trailing twelve months price to earnings ratio of 15.58. Meaning, the purchaser of the share is investing kr15.58 for every norwegian krone of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 23.89%.
Yearly Top and Bottom Value
VISTIN PHARMA’s stock is valued at kr24.00 at 17:20 EST, under its 52-week high of kr24.90 and way above its 52-week low of kr20.60.
Revenue Growth
Year-on-year quarterly revenue growth declined by 0.6%, now sitting on 440.62M for the twelve trailing months.
Sales Growth
VISTIN PHARMA’s sales growth is 10.6% for the ongoing quarter and 6.6% for the next.
More news about VISTIN PHARMA.
4. SATS (SATS.OL)
6.5% sales growth and 22.5% return on equity
Sats ASA provides fitness and training services in Norway, Sweden, Denmark, and Finland. It offers sportswear, fitness gear, bars, and energy drinks. The company operates fitness clubs under the SATS, ELIXIA, Fresh Fitness, and SATSYoga brand names. Sats ASA was founded in 1995 and is headquartered in Oslo, Norway.
Earnings Per Share
As for profitability, SATS has a trailing twelve months EPS of kr1.2.
PE Ratio
SATS has a trailing twelve months price to earnings ratio of 18.21. Meaning, the purchaser of the share is investing kr18.21 for every norwegian krone of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 22.5%.
Yearly Top and Bottom Value
SATS’s stock is valued at kr21.85 at 17:20 EST, below its 52-week high of kr22.80 and way above its 52-week low of kr10.16.
Volume
Today’s last reported volume for SATS is 335151 which is 63.11% below its average volume of 908638.
More news about SATS.
